ID   TSP2_HUMAN              Reviewed;        1172 AA.
AC   P35442; A6H8N1; A7E232; Q5RI52;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   18-JUN-2025, entry version 225.
DE   RecName: Full=Thrombospondin-2;
DE   Flags: Precursor;
GN   Name=THBS2; Synonyms=TSP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8406456; DOI=10.1006/geno.1993.1308;
RA   Labell T.L., Byers P.H.;
RT   "Sequence and characterization of the complete human thrombospondin 2 cDNA:
RT   potential regulatory role for the 3' untranslated region.";
RL   Genomics 17:225-229(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 560-1172.
RC   TISSUE=Fibroblast;
RX   PubMed=1559694; DOI=10.1016/0888-7543(92)90430-z;
RA   Labell T.L., McGookey Milewicz D.J., Disteche C.M., Byers P.H.;
RT   "Thrombospondin II: partial cDNA sequence, chromosome location, and
RT   expression of a second member of the thrombospondin gene family in
RT   humans.";
RL   Genomics 12:421-429(1992).
RN   [7]
RP   INTERACTION WITH THBS1 AND THBS2.
RX   PubMed=1371676; DOI=10.1016/0006-291x(92)91860-s;
RA   Asch A.S., Silbiger S., Heimer E., Nachman R.L.;
RT   "Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding.";
RL   Biochem. Biophys. Res. Commun. 182:1208-1217(1992).
RN   [8]
RP   DISULFIDE BONDS IN THROMBOSPONDIN DOMAIN.
RX   PubMed=11590138; DOI=10.1074/jbc.m104218200;
RA   Misenheimer T.M., Hahr A.J., Harms A.C., Annis D.S., Mosher D.F.;
RT   "Disulfide connectivity of recombinant C-terminal region of human
RT   thrombospondin 2.";
RL   J. Biol. Chem. 276:45882-45887(2001).
RN   [9]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO IDD, AND TISSUE SPECIFICITY.
RX   PubMed=18455130; DOI=10.1016/j.ajhg.2008.03.013;
RA   Hirose Y., Chiba K., Karasugi T., Nakajima M., Kawaguchi Y., Mikami Y.,
RA   Furuichi T., Mio F., Miyake A., Miyamoto T., Ozaki K., Takahashi A.,
RA   Mizuta H., Kubo T., Kimura T., Tanaka T., Toyama Y., Ikegawa S.;
RT   "A functional polymorphism in THBS2 that affects alternative splicing and
RT   MMP binding is associated with lumbar-disc herniation.";
RL   Am. J. Hum. Genet. 82:1122-1129(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=20714802; DOI=10.1007/s10549-010-1085-7;
RA   Koch M., Hussein F., Woeste A., Grundker C., Frontzek K., Emons G.,
RA   Hawighorst T.;
RT   "CD36-mediated activation of endothelial cell apoptosis by an N-terminal
RT   recombinant fragment of thrombospondin-2 inhibits breast cancer growth and
RT   metastasis in vivo.";
RL   Breast Cancer Res. Treat. 128:337-346(2011).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 551-1172 IN COMPLEX WITH CALCIUM
RP   IONS, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-584; ASN-710 AND ASN-1069.
RX   PubMed=16186819; DOI=10.1038/nsmb997;
RA   Carlson C.B., Bernstein D.A., Annis D.S., Misenheimer T.M., Hannah B.L.,
RA   Mosher D.F., Keck J.L.;
RT   "Structure of the calcium-rich signature domain of human
RT   thrombospondin-2.";
RL   Nat. Struct. Mol. Biol. 12:910-914(2005).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 551-1172, AND MUTAGENESIS OF
RP   ASN-702.
RX   PubMed=18499674; DOI=10.1074/jbc.m800223200;
RA   Carlson C.B., Liu Y., Keck J.L., Mosher D.F.;
RT   "Influences of the N700S thrombospondin-1 polymorphism on protein structure
RT   and stability.";
RL   J. Biol. Chem. 283:20069-20076(2008).
RN   [13]
RP   INVOLVEMENT IN EDSCLL3, AND VARIANT EDSCLL3 ARG-896.
RX   PubMed=38433265; DOI=10.1038/s41431-024-01559-1;
RA   Hadar N., Porgador O., Cohen I., Levi H., Dolgin V., Yogev Y.,
RA   Sued-Hendrickson S., Shelef I., Didkovsky E., Eskin-Schwartz M., Birk O.S.;
RT   "Heterozygous THBS2 pathogenic variant causes Ehlers-Danlos syndrome with
RT   prominent vascular features in humans and mice.";
RL   Eur. J. Hum. Genet. 32:550-557(2024).
CC   -!- FUNCTION: Adhesive glycoprotein that mediates cell-to-cell and cell-to-
CC       matrix interactions. Ligand for CD36 mediating antiangiogenic
CC       properties. {ECO:0000269|PubMed:20714802}.
CC   -!- SUBUNIT: Homotrimer; disulfide-linked. Interacts (via the TSP type I
CC       repeats) with CD36; the interaction conveys an antiangiogenic effect.
CC       Interacts (via the TSP type I repeats) with HRG; the interaction blocks
CC       the antiangiogenic effect of THBS2 with CD36 (By similarity). Can bind
CC       to fibrinogen, fibronectin, laminin and type V collagen. {ECO:0000250,
CC       ECO:0000269|PubMed:11590138, ECO:0000269|PubMed:1371676,
CC       ECO:0000269|PubMed:16186819}.
CC   -!- INTERACTION:
CC       P35442; P54290: Cacna2d1; Xeno; NbExp=2; IntAct=EBI-2466249, EBI-2466294;
CC   -!- TISSUE SPECIFICITY: High expression in invertebral disk tissue.
CC       {ECO:0000269|PubMed:18455130}.
CC   -!- DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common
CC       musculo-skeletal disorder caused by degeneration of intervertebral
CC       disks of the lumbar spine. It results in low-back pain and unilateral
CC       leg pain. {ECO:0000269|PubMed:18455130}. Note=Disease susceptibility is
CC       associated with variants affecting the gene represented in this entry.
CC   -!- DISEASE: Ehlers-Danlos syndrome, classic-like, 3 (EDSCLL3)
CC       [MIM:620865]: A form of Ehlers-Danlos syndrome, a group of connective
CC       tissue disorders characterized by skin hyperextensibility, articular
CC       hypermobility, and tissue fragility. EDSCLL3 is an autosomal dominant
CC       form. Affected individuals have joint hypermobility, frequent joint
CC       dislocations, atrophic scarring, prolonged bleeding time and age-
CC       related aortic dilatation and rupture. {ECO:0000269|PubMed:38433265}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the thrombospondin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/42549/THBS2";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L12350; AAA03703.1; -; mRNA.
DR   EMBL; M81339; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK292429; BAF85118.1; -; mRNA.
DR   EMBL; BX322234; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47455.1; -; Genomic_DNA.
DR   EMBL; BC146676; AAI46677.1; -; mRNA.
DR   EMBL; BC150175; AAI50176.1; -; mRNA.
DR   CCDS; CCDS34574.1; -.
DR   PIR; A47379; TSHUP2.
DR   RefSeq; NP_003238.2; NM_003247.3.
DR   RefSeq; XP_054212261.1; XM_054356286.1.
DR   PDB; 1YO8; X-ray; 2.60 A; A=551-1172.
DR   PDB; 2RHP; X-ray; 2.90 A; A=551-1172.
DR   PDBsum; 1YO8; -.
DR   PDBsum; 2RHP; -.
DR   AlphaFoldDB; P35442; -.
DR   SMR; P35442; -.
DR   BioGRID; 112916; 24.
DR   ComplexPortal; CPX-1788; Thrombospondin 2 complex.
DR   CORUM; P35442; -.
DR   FunCoup; P35442; 669.
DR   IntAct; P35442; 13.
DR   STRING; 9606.ENSP00000355751; -.
DR   GlyConnect; 1805; 24 N-Linked glycans (4 sites).
DR   GlyCosmos; P35442; 7 sites, 23 glycans.
DR   GlyGen; P35442; 11 sites, 75 N-linked glycans (4 sites), 1 O-linked glycan (4 sites).
DR   iPTMnet; P35442; -.
DR   PhosphoSitePlus; P35442; -.
DR   BioMuta; THBS2; -.
DR   DMDM; 215273908; -.
DR   CPTAC; CPTAC-1186; -.
DR   jPOST; P35442; -.
DR   MassIVE; P35442; -.
DR   PaxDb; 9606-ENSP00000355751; -.
DR   PeptideAtlas; P35442; -.
DR   ProteomicsDB; 55062; -.
DR   Antibodypedia; 33564; 236 antibodies from 26 providers.
DR   DNASU; 7058; -.
DR   Ensembl; ENST00000366787.7; ENSP00000355751.3; ENSG00000186340.17.
DR   Ensembl; ENST00000617924.6; ENSP00000482784.1; ENSG00000186340.17.
DR   Ensembl; ENST00000676498.1; ENSP00000504820.1; ENSG00000186340.17.
DR   Ensembl; ENST00000676760.1; ENSP00000503020.1; ENSG00000186340.17.
DR   GeneID; 7058; -.
DR   KEGG; hsa:7058; -.
DR   MANE-Select; ENST00000617924.6; ENSP00000482784.1; NM_003247.5; NP_003238.2.
DR   UCSC; uc003qwt.5; human.
DR   AGR; HGNC:11786; -.
DR   CTD; 7058; -.
DR   DisGeNET; 7058; -.
DR   GeneCards; THBS2; -.
DR   HGNC; HGNC:11786; THBS2.
DR   HPA; ENSG00000186340; Low tissue specificity.
DR   MalaCards; THBS2; -.
DR   MIM; 188061; gene.
DR   MIM; 603932; phenotype.
DR   MIM; 620865; phenotype.
DR   neXtProt; NX_P35442; -.
DR   OpenTargets; ENSG00000186340; -.
DR   PharmGKB; PA36498; -.
DR   VEuPathDB; HostDB:ENSG00000186340; -.
DR   eggNOG; ENOG502QRK8; Eukaryota.
DR   GeneTree; ENSGT00940000157846; -.
DR   HOGENOM; CLU_009257_0_0_1; -.
DR   InParanoid; P35442; -.
DR   OMA; MPGVMLQ; -.
DR   OrthoDB; 14563at2759; -.
DR   PAN-GO; P35442; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; P35442; -.
DR   TreeFam; TF324917; -.
DR   PathwayCommons; P35442; -.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-5083635; Defective B3GALTL causes PpS.
DR   Reactome; R-HSA-5173214; O-glycosylation of TSR domain-containing proteins.
DR   SignaLink; P35442; -.
DR   SIGNOR; P35442; -.
DR   BioGRID-ORCS; 7058; 10 hits in 1154 CRISPR screens.
DR   ChiTaRS; THBS2; human.
DR   EvolutionaryTrace; P35442; -.
DR   GeneWiki; THBS2; -.
DR   GenomeRNAi; 7058; -.
DR   Pharos; P35442; Tbio.
DR   PRO; PR:P35442; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P35442; protein.
DR   Bgee; ENSG00000186340; Expressed in pericardium and 190 other cell types or tissues.
DR   ExpressionAtlas; P35442; baseline and differential.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0031091; C:platelet alpha granule; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008201; F:heparin binding; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl.
DR   FunFam; 2.20.100.10:FF:000004; Adhesion G protein-coupled receptor B2; 1.
DR   FunFam; 4.10.1080.10:FF:000004; Cartilage oligomeric matrix protein; 1.
DR   FunFam; 2.20.100.10:FF:000007; Thrombospondin 1; 2.
DR   FunFam; 2.60.120.200:FF:000009; Thrombospondin 1; 1.
DR   FunFam; 2.10.25.10:FF:000070; Thrombospondin 2; 1.
DR   FunFam; 2.60.120.200:FF:000067; Thrombospondin 2; 1.
DR   FunFam; 2.10.25.10:FF:000025; Thrombospondin 3; 1.
DR   FunFam; 2.10.25.10:FF:000027; Thrombospondin 3; 1.
DR   FunFam; 4.10.1080.10:FF:000001; Thrombospondin 3; 1.
DR   FunFam; 4.10.1080.10:FF:000002; Thrombospondin 3; 1.
DR   Gene3D; 2.60.120.200; -; 2.
DR   Gene3D; 6.20.200.20; -; 1.
DR   Gene3D; 2.10.25.10; Laminin; 3.
DR   Gene3D; 2.20.100.10; Thrombospondin type-1 (TSP1) repeat; 3.
DR   Gene3D; 4.10.1080.10; TSP type-3 repeat; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR024731; EGF_dom.
DR   InterPro; IPR003367; Thrombospondin_3-like_rpt.
DR   InterPro; IPR017897; Thrombospondin_3_rpt.
DR   InterPro; IPR008859; Thrombospondin_C.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   InterPro; IPR028974; TSP_type-3_rpt.
DR   InterPro; IPR048287; TSPN-like_N.
DR   InterPro; IPR001007; VWF_dom.
DR   PANTHER; PTHR10199; THROMBOSPONDIN; 1.
DR   PANTHER; PTHR10199:SF10; THROMBOSPONDIN-2; 1.
DR   Pfam; PF12947; EGF_3; 1.
DR   Pfam; PF00090; TSP_1; 3.
DR   Pfam; PF02412; TSP_3; 6.
DR   Pfam; PF05735; TSP_C; 1.
DR   Pfam; PF00093; VWC; 1.
DR   PRINTS; PR01705; TSP1REPEAT.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00179; EGF_CA; 2.
DR   SMART; SM00209; TSP1; 3.
DR   SMART; SM00210; TSPN; 1.
DR   SMART; SM00214; VWC; 1.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 2.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   SUPFAM; SSF57603; FnI-like domain; 1.
DR   SUPFAM; SSF103647; TSP type-3 repeat; 3.
DR   SUPFAM; SSF82895; TSP-1 type 1 repeat; 3.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS50092; TSP1; 3.
DR   PROSITE; PS51234; TSP3; 8.
DR   PROSITE; PS51236; TSP_CTER; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Disease variant; Disulfide bond;
KW   EGF-like domain; Ehlers-Danlos syndrome; Glycoprotein; Heparin-binding;
KW   Proteomics identification; Reference proteome; Repeat; Signal.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..1172
FT                   /note="Thrombospondin-2"
FT                   /id="PRO_0000035846"
FT   DOMAIN          19..215
FT                   /note="Laminin G-like"
FT   DOMAIN          318..375
FT                   /note="VWFC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00220"
FT   DOMAIN          381..431
FT                   /note="TSP type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          437..492
FT                   /note="TSP type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          494..549
FT                   /note="TSP type-1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          549..589
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          648..692
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          693..728
FT                   /note="TSP type-3 1"
FT   REPEAT          729..764
FT                   /note="TSP type-3 2"
FT   REPEAT          765..787
FT                   /note="TSP type-3 3"
FT   REPEAT          788..823
FT                   /note="TSP type-3 4"
FT   REPEAT          824..846
FT                   /note="TSP type-3 5"
FT   REPEAT          847..884
FT                   /note="TSP type-3 6"
FT   REPEAT          885..920
FT                   /note="TSP type-3 7"
FT   REPEAT          921..956
FT                   /note="TSP type-3 8"
FT   DOMAIN          960..1172
FT                   /note="TSP C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00635"
FT   REGION          19..232
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          843..931
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           928..930
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        847..866
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        870..884
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        896..905
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        151
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        316
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        330
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        457
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        584
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16186819"
FT   CARBOHYD        710
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16186819"
FT   CARBOHYD        1069
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16186819"
FT   DISULFID        266
FT                   /note="Interchain"
FT                   /evidence="ECO:0000305"
FT   DISULFID        270
FT                   /note="Interchain"
FT                   /evidence="ECO:0000305"
FT   DISULFID        393..425
FT                   /evidence="ECO:0000250"
FT   DISULFID        397..430
FT                   /evidence="ECO:0000250"
FT   DISULFID        408..415
FT                   /evidence="ECO:0000250"
FT   DISULFID        449..486
FT                   /evidence="ECO:0000250"
FT   DISULFID        453..491
FT                   /evidence="ECO:0000250"
FT   DISULFID        464..476
FT                   /evidence="ECO:0000250"
FT   DISULFID        506..543
FT                   /evidence="ECO:0000250"
FT   DISULFID        510..548
FT                   /evidence="ECO:0000250"
FT   DISULFID        521..533
FT                   /evidence="ECO:0000250"
FT   DISULFID        553..564
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        558..574
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        577..588
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        594..610
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        601..619
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        622..646
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        652..665
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        659..678
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        680..691
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        707..715
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        720..740
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        756..776
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        779..799
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        815..835
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        838..858
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        876..896
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        912..932
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   DISULFID        948..1169
FT                   /evidence="ECO:0000269|PubMed:16186819,
FT                   ECO:0000269|PubMed:18499674, ECO:0007744|PDB:1YO8,
FT                   ECO:0007744|PDB:2RHP"
FT   VARIANT         133
FT                   /note="T -> S (in dbSNP:rs36088849)"
FT                   /id="VAR_045842"
FT   VARIANT         375
FT                   /note="L -> F (in dbSNP:rs35404985)"
FT                   /id="VAR_045843"
FT   VARIANT         896
FT                   /note="C -> R (in EDSCLL3; likely pathogenic)"
FT                   /evidence="ECO:0000269|PubMed:38433265"
FT                   /id="VAR_089735"
FT   MUTAGEN         702
FT                   /note="N->S: Alters protein stability."
FT                   /evidence="ECO:0000269|PubMed:18499674"
FT   CONFLICT        2
FT                   /note="V -> A (in Ref. 5; AAI50176)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        171..173
FT                   /note="DSF -> GPV (in Ref. 1; AAA03703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        576
FT                   /note="S -> F (in Ref. 1; AAA03703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1111
FT                   /note="R -> G (in Ref. 5; AAI46677)"
FT                   /evidence="ECO:0000305"
FT   HELIX           552..555
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          564..566
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          572..574
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          585..587
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            593..596
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          605..607
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          610..612
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          614..619
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          626..628
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          632..636
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           637..640
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          646..648
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            651..655
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          663..667
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          673..680
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          684..693
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          697..700
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            706..710
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          712..714
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          734..736
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            738..740
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          746..749
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            751..753
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            755..758
FT                   /evidence="ECO:0007829|PDB:2RHP"
FT   STRAND          767..772
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           774..776
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          793..795
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           797..799
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          805..808
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            810..812
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          829..831
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           833..835
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          851..854
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            856..858
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          866..869
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           871..873
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          890..892
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            894..896
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          903..905
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           907..909
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            911..914
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          926..928
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           930..932
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          939..941
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           943..945
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          960..968
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          971..973
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          979..982
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           983..985
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          987..990
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          995..1016
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1024..1033
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1036..1045
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1053..1055
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1061..1069
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   HELIX           1076..1083
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1084..1086
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            1089..1091
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1092..1097
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1110..1116
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   TURN            1118..1120
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1122..1129
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1132..1136
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1139..1141
FT                   /evidence="ECO:0007829|PDB:2RHP"
FT   STRAND          1148..1156
FT                   /evidence="ECO:0007829|PDB:1YO8"
FT   STRAND          1159..1169
FT                   /evidence="ECO:0007829|PDB:1YO8"
SQ   SEQUENCE   1172 AA;  129991 MW;  415BF376F4669F6A CRC64;
     MVWRLVLLAL WVWPSTQAGH QDKDTTFDLF SISNINRKTI GAKQFRGPDP GVPAYRFVRF
     DYIPPVNADD LSKITKIMRQ KEGFFLTAQL KQDGKSRGTL LALEGPGLSQ RQFEIVSNGP
     ADTLDLTYWI DGTRHVVSLE DVGLADSQWK NVTVQVAGET YSLHVGCDLI DSFALDEPFY
     EHLQAEKSRM YVAKGSARES HFRGLLQNVH LVFENSVEDI LSKKGCQQGQ GAEINAISEN
     TETLRLGPHV TTEYVGPSSE RRPEVCERSC EELGNMVQEL SGLHVLVNQL SENLKRVSND
     NQFLWELIGG PPKTRNMSAC WQDGRFFAEN ETWVVDSCTT CTCKKFKTIC HQITCPPATC
     ASPSFVEGEC CPSCLHSVDG EEGWSPWAEW TQCSVTCGSG TQQRGRSCDV TSNTCLGPSI
     QTRACSLSKC DTRIRQDGGW SHWSPWSSCS VTCGVGNITR IRLCNSPVPQ MGGKNCKGSG
     RETKACQGAP CPIDGRWSPW SPWSACTVTC AGGIRERTRV CNSPEPQYGG KACVGDVQER
     QMCNKRSCPV DGCLSNPCFP GAQCSSFPDG SWSCGSCPVG FLGNGTHCED LDECALVPDI
     CFSTSKVPRC VNTQPGFHCL PCPPRYRGNQ PVGVGLEAAK TEKQVCEPEN PCKDKTHNCH
     KHAECIYLGH FSDPMYKCEC QTGYAGDGLI CGEDSDLDGW PNLNLVCATN ATYHCIKDNC
     PHLPNSGQED FDKDGIGDAC DDDDDNDGVT DEKDNCQLLF NPRQADYDKD EVGDRCDNCP
     YVHNPAQIDT DNNGEGDACS VDIDGDDVFN ERDNCPYVYN TDQRDTDGDG VGDHCDNCPL
     VHNPDQTDVD NDLVGDQCDN NEDIDDDGHQ NNQDNCPYIS NANQADHDRD GQGDACDPDD
     DNDGVPDDRD NCRLVFNPDQ EDLDGDGRGD ICKDDFDNDN IPDIDDVCPE NNAISETDFR
     NFQMVPLDPK GTTQIDPNWV IRHQGKELVQ TANSDPGIAV GFDEFGSVDF SGTFYVNTDR
     DDDYAGFVFG YQSSSRFYVV MWKQVTQTYW EDQPTRAYGY SGVSLKVVNS TTGTGEHLRN
     ALWHTGNTPG QVRTLWHDPR NIGWKDYTAY RWHLTHRPKT GYIRVLVHEG KQVMADSGPI
     YDQTYAGGRL GLFVFSQEMV YFSDLKYECR DI
//
